Biomarkers in the Prediction of Cancer-Related Cognitive Impairment: Implications within Supportive Care
Research in Clinical Pharmacy · 2023
DOI: 10.59931/rcp.23.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research in Clinical Pharmacy, 2023. Verfasst von Alexandre Chan und 3 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BYNC 4.0).
Abstract (Originalsprache)
Patients and survivors of cancer may develop cognitive impairment pre-, intra-, and posttreatment, which is a phenomenon known as cancer-related cognitive impairment (CRCI) or chemobrain.CRCI can adversely affect the quality of life in patients and survivors of cancer.Several factors are associated with CRCI, and the proposed CRCI mechanisms include oxidative stress, dysregulation of inflammatory cytokines, genetic susceptibility, hormone deficiencies and/or psychological distress.Over the past 15 years (2008)(2009)(2010)(2011)(2012)(2013)(2014)(2015)(2016)(2017)(2018)(2019)(2020)(2021)(2022)(2023), our Singapore-and United States-based research team has conducted numerous human studies to evaluate the underlying mechanisms of CRCI through biomarker discovery and validation.Hence, this narrative review aims to elucidate the association between peripheral biomarkers evaluated in our past studies and cognitive function among non-CNS cancer survivors.In summary, plasma levels of brain-derived neurotrophic factor, inflammatory cytokines, and dynamin-1 in plasma extracellular vesicles have shown promising roles in CRCI pathophysiology.These findings indicate that further investigations are required to explore their potential to translate observational results into experimental therapeutics.
Zitieren
APA
Chan, A., Ng, D. Q., Yusuf, R., & Lu, W. (2023). Biomarkers in the Prediction of Cancer-Related Cognitive Impairment: Implications within Supportive Care. Research in Clinical Pharmacy. https://doi.org/10.59931/rcp.23.008
Vancouver
Chan A, Ng DQ, Yusuf R, Lu W. Biomarkers in the Prediction of Cancer-Related Cognitive Impairment: Implications within Supportive Care. Research in Clinical Pharmacy. 2023. doi:10.59931/rcp.23.008
BibTeX
@article{Chan2023,
author = {Chan, Alexandre and Ng, Ding Quan and Yusuf, Rukh and Lu, Wenjia},
title = {Biomarkers in the Prediction of Cancer-Related Cognitive Impairment: Implications within Supportive Care},
journal = {Research in Clinical Pharmacy},
year = {2023},
doi = {10.59931/rcp.23.008}
}
EUVIMED